Early Migraine Intervention With Sumatriptan 100 Mg in Patients With a History of Nonresponse to Sumatriptan 50 Mg: An Open-Label, Prospective Study of Multiple Attacks

Current Therapeutic Research - United States
doi 10.1016/j.curtheres.2004.06.003
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Treatment With Sumatriptan 50 Mg in the Mild Phase of Migraine Attacks in Patients With Infrequent Attacks: A Randomised, Double-Blind, Placebo-Controlled Study

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2006English

Treatment Satisfaction and Efficacy of the Rapid Release Formulation of Sumatriptan 100 Mg Tablets Utilising an Early Intervention Paradigm in Patients Previously Unsatisfied With Sumatriptan

International Journal of Clinical Practice
Medicine
2008English

Multimechanistic (Sumatriptan-Naproxen) Early Intervention for the Acute Treatment of Migraine

Neurology
Neurology
2009English

Pain Free Efficacy of Sumatriptan in the Early Treatment of Migraine

Canadian Journal of Neurological Sciences
MedicineNeurology
2006English

Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study

BMC Psychiatry
PsychiatryMental Health
2011English

Sumatriptan

Cephalalgia
MedicineNeurology
1992English

Zolmitriptan Versus Sumatriptan for the Acute Oral Treatment of Migraine: A Randomized, Double-Blind, International Study

European Journal of Neurology
Neurology
2001English

EXPLORE: A Prospective, Multinational, Natural History Study of Patients With Acute Hepatic Porphyria With Recurrent Attacks

Hepatology
MedicineHepatology
2019English

Adverse Reactions Attributed to Sumatriptan

European Journal of Clinical Pharmacology
MedicinePharmacology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy